Peripheral Artery Disease Market Set to Reach New Heights by 2023 as Demand for Innovative Treatments Rises

Peripheral artery disease (PAD) is a circulatory condition in which there is a narrowing or blockage of the blood vessels that carry blood from the heart to the legs and arms. It is caused by a buildup of fatty deposits or plaque within the walls of the arteries, which reduces blood flow to the limbs. PAD most commonly affects the arteries in the legs, but can also affect the arteries in the arms, stomach, and kidneys. Symptoms of PAD can include leg pain, cramping, or weakness, especially during physical activity, as well as numbness or tingling in the legs or feet.

Allied Market Research has published a study report with the title Peripheral Artery Disease Market Size is estimated to surpass around USD 5.71 billion by 2027, registering a CAGR of 8.5% from 2021 to 2027.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/4315

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐬𝐭𝐚𝐟𝐟𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭?

There are several driving factors and opportunities in the global Peripheral Artery Disease (PAD) market. Here are some of them, listed in no particular order:

Driving factors:

• Aging population: The global population is aging, which is a major risk factor for PAD. As the number of elderly people increases, so does the incidence of PAD, which drives the demand for PAD diagnosis and treatment.
• Prevalence of lifestyle diseases: Lifestyle diseases such as diabetes, obesity, and hypertension are major risk factors for PAD. The increasing prevalence of these diseases worldwide has led to a higher incidence of PAD, creating a demand for PAD diagnosis and treatment.
• Advancements in technology: Advances in medical technology, such as minimally invasive procedures and new drug therapies, have improved the diagnosis and treatment of PAD. This has increased the demand for PAD diagnosis and treatment.
• Government initiatives: Governments in many countries are investing in healthcare infrastructure and implementing policies to improve healthcare services, which has led to increased awareness and diagnosis of PAD.

Opportunities:

• Rising demand for minimally invasive procedures: Minimally invasive procedures such as angioplasty and stenting are becoming increasingly popular for PAD treatment due to their lower risk, shorter hospital stays, and faster recovery times. This creates opportunities for medical device companies that specialize in PAD treatment devices.
• Increasing demand for novel therapies: Despite advancements in treatment options, there is still a need for new therapies for PAD. This creates opportunities for pharmaceutical companies that are developing new drugs to treat PAD.
• Growing demand for diagnostic devices: The demand for accurate and non-invasive diagnostic devices for PAD is increasing, creating opportunities for medical device companies that specialize in diagnostic devices for PAD.
• Expansion into emerging markets: The PAD market in emerging markets such as Asia-Pacific, Latin America, and the Middle East is growing, providing opportunities for medical device and pharmaceutical companies to expand their services in these regions.
• Collaboration and partnerships: Collaboration and partnerships between medical device companies, pharmaceutical companies, and healthcare providers can lead to the development of new and innovative solutions for PAD diagnosis and treatment, as well as improved patient outcomes.

𝐓𝐨𝐩 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical
• Cardinal Health, Inc.
• Becton, Dickinson and Company
• Terumo Corporation
• Koninklijke Philips N.V
• AngioDynamics, Inc.
• BIOTRONIK
• B. Braun Melsungen AG

𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

Based on type, the peripheral stents segment contributed to the largest market share, holding nearly two-fifths of the total share of the global peripheral artery disease market in 2019, and is expected to maintain its highest contribution during the forecast period. This is attributed to technological innovations leading to development of bio-engineered stents, dual therapy stents, and EPC capture stents. However, the plaque modification devices segment is expected to grow at the largest CAGR of 9.5% from 2020 to 2027. This is due to necessity of these devices while ballooning of arteries fail.

Based on region, North America accounted for the highest share in terms of revenue, contributing to nearly two-fifths of the global peripheral artery disease market in 2019, and will maintain its lead position during the forecast period. This is due to changes in lifestyle habits such as unhealthy dietary habits, smoking, excessive alcohol consumption, and lack of physical activity of people in the region.

However, Asia-Pacific is expected to grow at the highest CAGR of 9.4% from 2020 to 2027, owing to expansion of healthcare budgets, rise in disposable income, and surge in demand for technologically advanced devices.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/4315

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Top Trending Report:

• Gene Therapy Market: https://www.alliedmarketresearch.com/gene-therapy-market
• 3D Cell Culture Market: https://www.alliedmarketresearch.com/3d-cell-cultures-market
• Molecular diagnostics market: https://www.alliedmarketresearch.com/molecular-diagnostics-market
• MRI Coils Market: https://www.alliedmarketresearch.com/mri-coils-market-A14839
• Ambulance Services Market- https://www.alliedmarketresearch.com/ambulance-services-market-A31884
• Lab Information Management System Market: https://www.alliedmarketresearch.com/lab-information-management-systems-market-A53480
• Healthcare Staffing Market:https://www.alliedmarketresearch.com/healthcare-staffing-market-A31394
• Medical Device Cleaning Market: https://www.alliedmarketresearch.com/medical-device-cleaning-market-A31883
• Audiology Devices Market: https://www.alliedmarketresearch.com/audiology-devices-market

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.